[email protected] |
MTN-020 ACASI Support |
[email protected] |
MTN-020 Accrual, Retention, and Outreach Team |
[email protected] |
MTN-020 Adherence Working Group |
[email protected] |
MTN-020 Community Working Group |
[email protected] |
MTN-020 FDA Audit Planning |
[email protected] |
MTN-020 Investigators of Record |
[email protected] |
MTN-020 Laboratory |
[email protected] |
MTN-020 MRC Site Clinicians |
[email protected] |
MTN-020 Pharmacists |
[email protected] |
MTN-020 Protocol Safety Review Team |
[email protected] |
MTN-020 Protocol Team |
[email protected] |
MTN-020 Publication Calls |
[email protected] |
MTN-020 Publications Committee |
[email protected] |
MTN-020 QA/QC Team |
[email protected] |
MTN-020 Qualitative Group |
[email protected] |
MTN-020 Qualitative Management Team |
[email protected] |
MTN-020 Qualitative Pub Committee |
[email protected] |
MTN-020 Regulatory |
[email protected] |
MTN-020 Safety MDs |
[email protected] |
MTN-020 Site Clinicians |
[email protected] |
MTN-020 South African Regulatory |
[email protected] |
MTN-020 Study Coordinators |
[email protected] |
MTN-020 Study Counselors |
[email protected] |
MTN-020 Study Management Team |